| 0 (0%) | 11-11 17:47 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 4.83 |
1-year : | 5.13 |
| Resists | First : | 4.13 |
Second : | 4.4 |
| Pivot price | 3.99 |
|||
| Supports | First : | 3.71 |
Second : | 3.08 |
| MAs | MA(5) : | 3.9 |
MA(20) : | 4.02 |
| MA(100) : | 3.86  |
MA(250) : | 3.57 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 19.1 |
D(3) : | 28.5 |
| RSI | RSI(14): 37.5 |
|||
| 52-week | High : | 5.05 | Low : | 1.86 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ KRMD ] has closed above bottom band by 6.6%. Bollinger Bands are 5.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.04 - 4.06 | 4.06 - 4.08 |
| Low: | 3.66 - 3.68 | 3.68 - 3.7 |
| Close: | 3.69 - 3.72 | 3.72 - 3.76 |
Tue, 11 Nov 2025
KORU Medical Systems Inc (KRMD) Q3 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Tue, 11 Nov 2025
Is KRMD building a consolidation base - Weekly Trend Recap & Stock Portfolio Risk Control - newser.com
Mon, 10 Nov 2025
Is KRMD stock oversold or undervalued - Trade Volume Summary & Growth Focused Investment Plans - newser.com
Mon, 10 Nov 2025
Will KRMD stock outperform growth indexes - Watch List & Real-Time Buy Signal Alerts - newser.com
Sun, 09 Nov 2025
Analyzing drawdowns of KRMD with statistical tools - July 2025 Reactions & Intraday High Probability Setup Alerts - newser.com
Tue, 04 Nov 2025
KORU Medical (NASDAQ: KRMD) to develop SCIg system for vials and prefilled syringes - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 46 (M) |
| Shares Float | 34 (M) |
| Held by Insiders | 8.3 (%) |
| Held by Institutions | 55.3 (%) |
| Shares Short | 847 (K) |
| Shares Short P.Month | 1,100 (K) |
| EPS | -0.11 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.36 |
| Profit Margin | -12.3 % |
| Operating Margin | -3.1 % |
| Return on Assets (ttm) | -11.5 % |
| Return on Equity (ttm) | -25.7 % |
| Qtrly Rev. Growth | 20.8 % |
| Gross Profit (p.s.) | 0.5 |
| Sales Per Share | 0.79 |
| EBITDA (p.s.) | -0.09 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -1 (M) |
| Levered Free Cash Flow | -1 (M) |
| PE Ratio | -37.3 |
| PEG Ratio | 0 |
| Price to Book value | 10.36 |
| Price to Sales | 4.67 |
| Price to Cash Flow | -252.79 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|